1.
Clin Vaccine Immunol
; 17(1): 194-8, 2010 Jan.
Article
in English
| MEDLINE
| ID: mdl-19889938
ABSTRACT
A blocking enzyme-linked immunosorbent assay (ELISA) with a baculovirus-expressed structural protein was developed for the detection of antibodies to foot-and-mouth disease virus type A. It exhibited 99% specificity with a cutoff of 53% inhibition. Its sensitivity was comparable to the sensitivities of the virus neutralization test and the liquid-phase blocking ELISA, indicating its potential as an alternative assay.